Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusion

被引:30
|
作者
Harding, Pamela [1 ]
Yang, Xiao-Ping [1 ]
He, Quan [1 ]
LaPointe, Margot C. [1 ]
机构
[1] Henry Ford Hosp, Hypertens & Vasc Res Div, Dept Internal Med, Detroit, MI 48202 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2011年 / 300卷 / 03期
关键词
microsomal prostaglandin E synthase-1; angiotensin II; hypertrophy; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; MICE LACKING; VENTRICULAR MYOCYTES; PRESSOR-RESPONSE; GENE-EXPRESSION; KNOCKOUT MICE; HYPERTENSION; INHIBITION; RECEPTOR;
D O I
10.1152/ajpheart.00772.2010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Harding P, Yang XP, He Q, LaPointe MC. Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusion. Am J Physiol Heart Circ Physiol 300: H1053-H1061, 2011. First published December 30, 2010; doi: 10.1152/ajpheart.00772.2010.-Our laboratory previously reported that inducible PGE(2) synthase, mPGES-1, contributes to micromolar production of PGE(2) in neonatal ventricular myocytes in vitro, which stimulates their growth. We therefore hypothesized that mPGES-1 contributes to cardiac hypertrophy following angiotensin II (ANG II) infusion. To test this hypothesis, we used 10-to 12-wk-old mPGES-1 knockout mice (mPGES-1 KO) and C57Bl/6 control mice infused for 8 wk with either 1.4 mg.kg(-1).day(-1) ANG II or vehicle subcutaneously. Blood pressure [systolic blood pressure (SBP)] was measured throughout the study, and cardiac function was assessed by M-mode echocardiography at baseline and at 8 wk of infusion. At the conclusion of the study, immunohistochemistry was used to evaluate collagen fraction, myocyte cross-sectional area (MCSA), and apoptosis. At baseline, there was no difference in SBP between mPGES-1 KO mice and C57BL/6 controls. ANG II infusion increased SBP to similar levels in both strains. In control mice, infusion of ANG II increased MCSA and posterior wall thickness at diastole (PWTd) but had little effect on cardiac function, consistent with compensatory hypertrophy. In contrast, cardiac function was worse in mPGES-1 KO mice after ANG II treatment. Ejection fraction declined from 76.2 +/- 2.7 to 63.3 +/- 3.4% after ANG II, and left ventricular dimension at systole and diastole increased from 1.29 +/- 0.02 to 1.78 +/- 0.15 mm and from 2.57 +/- 0.03 to 2.90 +/- 0.13 mm, respectively. Infusion of ANG II increased both the LV-to-body weight and the mass-to-body weight ratios to a similar extent in both strains. However, PWTd increased by a lesser extent in KO mice, suggesting an impaired hypertrophic response. ANG II infusion increased collagen staining similarly in both strains, but TdT-dUTP nick end labeling staining was greater in mPGES-1 KO mice. Overall, these results are consistent with a beneficial effect for mPGES-1 in the maintenance of cardiac function in ANG II-dependent hypertension.
引用
收藏
页码:H1053 / H1061
页数:9
相关论文
共 50 条
  • [21] The Impact of Microsomal Prostaglandin E Synthase 1 on Blood Pressure Is Determined by Genetic Background
    Facemire, Carie S.
    Griffiths, Robert
    Audoly, Laurent P.
    Koller, Beverly H.
    Coffman, Thomas M.
    HYPERTENSION, 2010, 55 (02) : 531 - 538
  • [22] Microsomal prostaglandin E synthase-1 is a critical factor in dopaminergic neurodegeneration in Parkinson's disease
    Ikeda-Matsuo, Yuri
    Miyata, Hajime
    Mizoguchi, Tomoko
    Ohama, Eisaku
    Naito, Yasuhito
    Uematsu, Satoshi
    Akira, Shizuo
    Sasaki, Yasuharu
    Tanabe, Mitsuo
    NEUROBIOLOGY OF DISEASE, 2019, 124 : 81 - 92
  • [23] Microsomal Prostaglandin E Synthase-1 Deficiency Exacerbates Pulmonary Fibrosis Induced by Bleomycin in Mice
    Wei, Bo
    Cai, Linhong
    Sun, Dan
    Wang, Yanhua
    Wang, Cairui
    Chai, Xiaoyu
    Xie, Feng
    Su, Ming
    Ding, Fangrui
    Liu, Jie
    Yang, Jichun
    Guan, Youfei
    Liu, Xinmin
    MOLECULES, 2014, 19 (04): : 4967 - 4985
  • [24] Invalidation of Microsomal Prostaglandin E Synthase-1 (mPGES-1) Reduces Diet-Induced Low-Grade Inflammation and Adiposity
    Pierre, Clement
    Guillebaud, Florent
    Airault, Coraline
    Barii, Nathalie
    Barbouche, Rym
    Save, Etienne
    Gaige, Stephanie
    Bariohay, Bruno
    Dallaporta, Michel
    Troadec, Jean-Denis
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [25] Deletion of Microsomal Prostaglandin E Synthase-1 Does Not Alter Ozone-Induced Airway Hyper-Responsiveness
    Wang, Miao
    Cooper, Philip R.
    Jiang, Meiqi
    Zhao, Hengjiang
    Hui, Yiqun
    Yao, Yubing
    Tate, Joshua C.
    Damera, Gautam
    Lawson, John A.
    Jester, William F., Jr.
    Haczku, Angela
    Panettieri, Reynold A., Jr.
    FitzGerald, Garret A.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (01) : 63 - 68
  • [26] Lack of Microsomal Prostaglandin E2 Synthase-1 in Bone Marrow-Derived Myeloid Cells Impairs Left Ventricular Function and Increases Mortality After Acute Myocardial Infarction
    Degousee, Norbert
    Simpson, Jeremy
    Fazel, Shafie
    Scholich, Klaus
    Angoulvant, Denis
    Angioni, Carlo
    Schmidt, Helmut
    Korotkova, Marina
    Stefanski, Eva
    Wang, Xing-Hua
    Lindsay, Thomas F.
    Ofek, Efrat
    Pierre, Sandra
    Butany, Jagdish
    Jakobsson, Per-Johan
    Keating, Armand
    Li, Ren-Ke
    Nahrendorf, Matthias
    Geisslinger, Gerd
    Backx, Peter H.
    Rubin, Barry B.
    CIRCULATION, 2012, 125 (23) : 2904 - +
  • [27] Anti-inflammatory and analgesic activity of a novel inhibitor of microsomal prostaglandin E synthase-1 expression
    Dolores Guerrero, Maria
    Aquino, Maurizio
    Bruno, Ines
    Riccio, Raffaele
    Carmen Terencio, Maria
    Paya, Miguel
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 620 (1-3) : 112 - 119
  • [28] Inhibition of microsomal prostaglandin E synthase-1 facilitates liver repair after hepatic injury in mice
    Nishizawa, Nobuyuki
    Ito, Yoshiya
    Eshima, Koji
    Ohkubo, Hirotoki
    Kojo, Ken
    Inoue, Tomoyoshi
    Raouf, Joan
    Jakobsson, Per-Johan
    Uematsu, Satoshi
    Akira, Shizuo
    Narumiya, Shuh
    Watanabe, Masahiko
    Majima, Masataka
    JOURNAL OF HEPATOLOGY, 2018, 69 (01) : 110 - 120
  • [29] Microsomal Prostaglandin E Synthase-1 Expression by Aortic Smooth Muscle Cells Attenuates the Differentiated Phenotype
    Adedoyin, Oreoluwa O.
    Loftin, Charles D.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2016, 68 (02) : 127 - 142
  • [30] Microsomal prostaglandin E2 synthase-1 and its inhibitors: Molecular mechanisms and therapeutic significance
    Zhang, Yan-Yu
    Yao, Yun-Da
    Luo, Jin-Fang
    Liu, Zhong-Qiu
    Huang, Yu-Ming
    Wu, Fei-Chi
    Sun, Qin-Hua
    Liu, Jian-Xin
    Zhou, Hua
    PHARMACOLOGICAL RESEARCH, 2022, 175